Contribute
Tour
Shop
About MicrobeTV
People
Latest Podcasts
Shows
Latest Podcasts
Infectious Disease Puscast #2
May 17, 2022
On the the second episode of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 4/27/22 – 5/11/22. Hosts: Daniel Griffin and Sara Dong Click arrow to playDownload Puscast 002 (33 MB .mp3, 54 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode •Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022 (MMWR)•Case Series of False-Positive HIV Test Results in Pediatric Acute Lymphoblastic Leukemia Patients Following Chimeric Antigen Receptor T-Cell Therapy: Guidance on How to Avoid and Resolve Diagnostic Dilemmas (JPIDS)•Immunological correlates of prevention of the onset of seasonal H3N2 influenza (JID)•Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 (MMWR)•Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults(MMWR)•The Role of C-Reactive Protein as a Triage Tool for Pulmonary Tuberculosis in Children (JPIDS)•Factors Potentially Contributing to the Contamination of Packaged Leafy Greens Implicated in the Outbreak of Salmonella Typhimurium During the Summer of 2021 (FDA)•Short-course intravenous antibiotics for young infants with urinary tract infection (Arch Dis Children)•Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence (Clin Inf Dis)•2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults (Clin Inf Dis)•Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa (Lancet)•Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults (JAMA)•Persistent MRSA Bacteremia: Resetting the Clock for Optimal Management (Clin Inf Dis)•Frequency and Duration of, and Risk Factors for, Diagnostic Delays Associated with Histoplasmosis (J Fungi)•Intestinal parasitic infections and associated factors among people living with HIV attending Dessie Referral Hospital, Dessie town, North-east Ethiopia (AIDS Res Ther)•Association of zoonotic protozoan parasites with microplastics in seawater and implications for human and wildlife health (Nat Sci Rep)•Climate change increases cross-species viral transmission risk (Nature and TWiV 898) Intro music is by Ronald JenkeesSend your questions for Puscast to puscast@microbe.tv...
Read more...
TWiV 900: Burning down the mouse
May 15, 2022
TWiV celebrates 900 episodes, Vincent gives the Richard R. Ernst lecture, and we discuss why inflammasome activation in infected macrophages drives severe COVID-19. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker Click arrow to playDownload TWiV 900 (65 MB .mp3, 108 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Richard R. Ernst Lecture 8:07Infected macrophages drives severe COVID-19 (Nature) 17:50Timestamps by Jolene. Thanks! Weekly Picks 1:17:45 Brianne – The Milky Way’s Black Hole Comes to LightKathy – River dolphins playing with anacondaRich – Smallpox vaccination techniques; from knives and forks to needles and pinsAlan – Vacuum Tubes: a Modern Aladdin’s LampVincent – Books by Pamela Jane Intro music is by Ronald JenkeesSend your virology questions and comments to twiv@microbe.tv...
Read more...
TWiV 899: COVID-19 clinical update #114 with Dr. Daniel Griffin
May 14, 2022
In COVID-19 clinical update #114, Dr. Griffin discusses early treatment with ivermectin, procalcitonin not a reliable biomarker, vaccine in 6-11 year olds, FDA limits use of Janssen vaccine, does site of vaccine booster matter, sniffer dogs, monoclonals for hospitalized patients, risk assessment for public events, Paxlovid eligibility, and persistence of pediatric anosmia. Click arrow to playDownload TWiV 899 (34 MB .mp3, 56 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Effects of early treatment with Ivermectin (NEJM) 36:01Procalcitonin not a reliable biomarker (IDSA) 43:08Evaluation of vaccine in children 6 to 11 years (NEJM) 2:40FDA limits use of Janssen vaccine (FDA) 24:48Recall of B cell memory on vaccination location (Science Immunology) 26:22Persistence screening using sniffer dogs (Journal of Clinical Trials) 13:24Tixagevimab/Cilgavimab for treatment of hospitalized patients (Lancet) 28:13Infection detection by canine olfaction (OFID) 10:40Diagnostic utility to differentiate patients (IDSA) 43:55Prevalence of anosmia in pediatric cases (Pediatric Infectious Disease Journal) 7:22Risk assessment for public events (University of Texas COVID-19 Modeling Consortium) 17:03PAXLOVID patient eligibility screening checklist (FDA) 33:01PAXLOVID drug interactions (IDSA) 34:36Contribute to ASTMH fundraiser at PWB 48:05Dr. Griffin’s treatment guide (pdf)Letters read on TWiV 899 48:41Timestamps by Jolene. Thanks! Intro music is by Ronald JenkeesSend your questions for Dr. Griffin to daniel@microbe.tv...
Read more...
TWiV 898: Immunity is skin deep
May 8, 2022
TWiV explains why the concept of herd immunity might not apply to COVID-19, and the observation that smallpox vaccination causes an increase in skin bacteria that promote pathology and influence the immune response. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Click arrow to playDownload TWiV 898 (65 MB .mp3, 108 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Herd immunity may not apply to COVID-19 (J Inf Dis) 2:58Smallpox vaccination increases skin bacteria (PLoS Path) 27:29The invinceable TWiV (TWiV 145) 36:29By the pricking of my thumbs… (TWiV 284) 36:43Letters read on TWiV 898 1:10:06Timestamps by Jolene. Thanks! Weekly Picks 1:27:50 Brianne – Bacteria and Me Coloring BookKathy – Smarter 3D printingRich – Big Ben Restoring the Worlds Most Famous Clock 2021Vincent – Scientific review articles as antivaccine disinformation Listener Pick Suellen – Your Fantastic Mind Season 3 Ep 2: Long COVID and Making of a Brain Surgeon (Full Episode) Intro music is by Ronald JenkeesSend your virology questions and comments to twiv@microbe.tv...
Read more...
TWiV 897: COVID-19 clinical update #113 with Dr. Daniel Griffin
May 7, 2022
In COVID-19 clinical update #113, Dr. Griffin discusses tocilizumab use in hospitalized Patients, IL-6 inhibitors and mortality, Baricitinib in hospitalized patients, post-infection neurological sequelae, comparative effectiveness of Pfizer and Moderna vaccines, phase 2/3 study of Paxlovid, infection relapse following Paxlovid, pre-hospital administration of Remdesivir, and hospitalization with different variants. Click arrow to playDownload TWiV 897 (29 MB .mp3, 48 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Timing of Tocilizumab Use in Hospitalized Patients (NIH) 34:28Interleukin-6 inhibitors reduce mortality (European Journal of Internal Medicine) 35:58Treatment Effect of Baricitinib on Hospitalized Patients (IDSA) 36:57Post Infection Neurological Sequelae (Res Square) 38:09Comparative Effectiveness of Pfizer and Moderna Vaccines (Nature Commun) 7:58Results from Phase 2/3 Study of Paxlovid (Pfizer) 13:45Infection Relapse Following Suppression by Paxlovid (Res Square) 19:55Update on Paxlovid Usage (FDA) 25:02Availability and Use of Treatments in Outpatients (CDC) 25:47Pre-Hospital Administration of Remdesivir (IDSA) 26:56Remdesivir and three other drugs for Hospitalized Patients (Lancet) 32:45Guidelines on Usage of Anticoagulants (Am Soc Hematol) 30:22Different Variants Hospitalization and Morality (Res Square) 3:30Contribute to FIMRIC fundraiser at PWB 40:26Dr. Griffin’s treatment guide (pdf)Letters read on TWiV 897 41:25Timestamps by Jolene. Thanks! Intro music is by Ronald JenkeesSend your questions for Dr. Griffin to daniel@microbe.tv...
Read more...
TWiM 264: Antimicrobial antipsychotics
May 6, 2022
TWiM reveals that the atypical antipsychotic quetiapine promotes multiple antibiotic resistance in E. coli, and treatment with Bifidobacterium lactis probiotic benefits patients with coronary artery disease. Hosts: Vincent Racaniello, Michael Schmidt, Michele Swanson, and Petra Levin Right click to download TWiM #264 (48 MB .mp3, 66 minutes) Subscribe to TWiM (free) on Apple Podcasts, Google Podcasts, Stitcher, Android, RSS, or by email. Become a Patron of TWiM! Links for this episode: Antipsychotic promotes antimicrobial resistance (J Bact)Probiotic benefits patients with coronary artery disease (mSystems)B. lactis and Alzheimer’s in mice (Eur J Nutr)Letters read on TWiM 264 Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Send your microbiology questions and comments to twim@microbe.tv...
Read more...
Infectious Disease Puscast #1
May 5, 2022
On the first episode of the Infectious Disease Puscast, Daniel and Sara bring Marc Crislip’s well known Puscast back to life, and present a review of the infectious disease literature for the previous two weeks, 4/13 – 4/27/22. Hosts: Daniel Griffin and Sara Dong Click arrow to playDownload Puscast 001 (33 MB .mp3, 54 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode Rabies from an anteater (MMWR)Oral Tebipenem Pivoxil Hydrobromide in Complicated UTI (NEJM)Therapeutic monitoring of vancomycin for serious MRSA infections (IDSA)Time to retire Vancomycin for MRAS Endovascular Infections? (Op Forum Inf Dis)Impact of ID consultation on outcome of patients with enterococcal bacteremia (Op Forum Inf Dis)Effect of Gram Stain–Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia (JAMA)Effect of Antimicrobial Prophylaxis Duration on Health Care-Associated Infections After Clean Orthopedic Surgery (JAMA)Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection (Op Forum Inf Dis)Vehicle Windshield Wiper Fluid as Potential Source of Sporadic Legionnaires’ Disease in Commercial Truck Drivers (EID)Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis (NEJM)High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine (JID)Association of Reduced Long-Lasting Insecticidal Net Efficacy and Pyrethroid Insecticide Resistance With Overexpression of CYP6P4, CYP6P3, and CYP6Z1 in Populations of Anopheles coluzzii From Southeast Côte d’Ivoire (J Inf Dis) Intro music is by Ronald JenkeesSend your questions for Puscast to puscast@microbe.tv...
Read more...
TWiP 205: Two for the price of one
May 3, 2022
The TWiP team solves the case of the Pregnant Ghanian Living Near a River, and reveal emodepside, a drug for treatment of onchocerciasis. Hosts: Vincent Racaniello, Dickson Despommier, Daniel Griffin, and Christina Naula Click arrow to playDownload TWiP #205 (56 MB .mp3, 93 minutes) Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Links for this episode Emodepside for onchocerciasis (PlOS NTD)Hero: Dr. Mwelecele Ntuli MalecelaLetters read on TWiP 205 Become a patron of TWiP Case Study for TWiP 205 Two women, 80s and 50s. Former had 9 children, lives in Ghanian village with large lagoon, many mosquitoes. Concerned about chronic swelling of left leg, groin area for much of her life. Walks barefoot. 50 yo with 4 children, both legs started to swell, cold, mosquito bites. With time left leg becomes hard, swollen, disfigured. Has gone to hospital for ulceration. Common problem in her village, mostly women but some men. Problems getting access to medications. Send your case diagnosis, questions and comments to twip@microbe.tv Music by Ronald Jenkees...
Read more...
Immune 55: Cells that suck at their job
May 3, 2022
Immune reveals a CD8+ regulatory subset of T cell subset that suppress pathogenic T cells and are active in autoimmune diseases and infectious diseases including COVID-19. Hosts: Vincent Racaniello, Cynthia Leifer, Steph Langel, and Brianne Barker Click arrow to playDownload Immune 55 (42 MB .mp3, 69 min)Subscribe (free): Apple Podcasts, Google Podcasts. RSS, emailBecome a patron of Immune! Links for this episode KIR+CD8+ regulatory T cells (Science) 2:46Time stamps by Jolene. Thanks! Music by Steve Neal. Immune logo image by Blausen MedicalSend your immunology questions and comments to immune@microbe.tv...
Read more...
TWiN 29: Astrocytes close the critical period
May 2, 2022
TWiN explains the finding that in the mouse visual cortex, astrocytes are key elements in the experience-dependent wiring of brain circuits. Hosts: Vincent Racaniello, Jason Shepherd, Timothy Cheung, and Vivianne Morrison Click arrow to playDownload TWiN 028 (44 MB .mp3, 74 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Links for this episode Astrocytes close the critical period (Science) 3:14, 27:00Timestamps by Jolene. Thanks! Music is by Ronald Jenkees Send your neuroscience questions and comments to twin@microbe.tv...
Read more...
TWiV 896: Memory B cells, the way we were
May 1, 2022
TWiV explains a study of how climate change is predicted to increase cross-species viral transmission risk, and increased memory B cell potency and breadth after a SARS-CoV-2 mRNA vaccine boost. Hosts: Vincent Racaniello, Dickson Despommier, and Amy Rosenfeld Click arrow to playDownload TWiV 896 (65 MB .mp3, 108 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Climate change and viral zoonosis risk (Nature) 4:14COVID-19 mRNA boost effect on memory B cells (Nature) 38:08Letters read on TWiV 896 1:19:04Timestamps by Jolene. Thanks! Weekly Picks 1:32:48 Dickson – Toots ThilelemansAmy – Largest comet ever identifiedVincent – Scientific review articles as antivaccine disinformation Intro music is by Ronald JenkeesSend your virology questions and comments to twiv@microbe.tv...
Read more...
TWiV 895: COVID-19 clinical update #112 with Dr. Daniel Griffin
April 30, 2022
In COVID-19 clinical update #112, Dr. Griffin reviews seroprevalence of infection-induced antibodies, Moderna filing for vaccine authorization in young children, public health impact of vaccines in US, FDA approval of first treatment for young children, phase 2 data for Sabizabulin, and post infection inflammation. Click arrow to playDownload TWiV 895 (33 MB .mp3, 54 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Seroprevalence of Infection-Induced Antibodies (CDC) 5:10Authorization for Vaccine in Young Children Filed (Moderna) 9:04Public Health Impact of Vaccines in US (BMJ) 13:47FDA authorizes first approved treatment for children (FDA) 16:32Phase 2 Data for Sabizabulin (Veru Pharma) 26:05Clinical Characteristics of Post Infection Inflammation (The Lancet) 28:27Fact Sheet for Providers on Evusheld (FDA) 1:32Fact Sheet for Providers on Paxlovid (FDA) 1:32Provider Referral for EvuSheld (Northwell Health) 16:00Contribute to ASTMH fundraiser at PWB 30:44Dr. Griffin’s treatment guide (pdf)Letters read on TWiV 895 31:19Timestamps by Jolene. Thanks! Intro music is by Ronald JenkeesSend your questions for Dr. Griffin to daniel@microbe.tv...
Read more...
Contribute
Support our work at
Patreon, PayPal, and more
. MicrobeTV, Inc. is a 501(c)3 non-profit organization.
